The New Face of Traditional Chinese Medicine

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.sciencemag.org/content/vol299/issue5604/news-summaries.shtml

ASIAN MEDICINE:
The New Face of Traditional Chinese Medicine

Dennis Normile

TOKYO--This year, the U.S. Food and Drug Administration approved a phase II trial to test the efficacy of Kanglaite in treating non-small-cell lung cancer, making Kanglaite the first drug derived from a traditional Chinese herbal remedy to go into clinical trials in the United States. Asian governments are hoping that high-volume screening and rigorous clinical trials will unlock the secrets of ancient herbal remedies--and that the results will pass muster with Western scientists.

Full Text

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.